- Home
- AKTX vs HKIT Comparison
AKTX vs HKIT Comparison
Compare AKTX & HKIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AKTX
- HKIT
- Stock Information
- Founded
- AKTX N/A
- HKIT 1996
- Country
- AKTX United States
- HKIT China
- Employees
- AKTX N/A
- HKIT N/A
- Industry
- AKTX Biotechnology: Pharmaceutical Preparations
- HKIT Computer Software: Prepackaged Software
- Sector
- AKTX Health Care
- HKIT Technology
- Exchange
- AKTX Nasdaq
- HKIT Nasdaq
- Market Cap
- AKTX 35.7M
- HKIT 39.8M
- IPO Year
- AKTX N/A
- HKIT 2023
- Fundamental
- Price
- AKTX $1.01
- HKIT $1.53
- Analyst Decision
- AKTX Strong Buy
- HKIT
- Analyst Count
- AKTX 1
- HKIT 0
- Target Price
- AKTX $5.00
- HKIT N/A
- AVG Volume (30 Days)
- AKTX 39.3K
- HKIT 21.5K
- Earning Date
- AKTX 08-13-2025
- HKIT 04-29-2025
- Dividend Yield
- AKTX N/A
- HKIT N/A
- EPS Growth
- AKTX N/A
- HKIT N/A
- EPS
- AKTX N/A
- HKIT N/A
- Revenue
- AKTX N/A
- HKIT $2,904,950.00
- Revenue This Year
- AKTX N/A
- HKIT N/A
- Revenue Next Year
- AKTX N/A
- HKIT N/A
- P/E Ratio
- AKTX N/A
- HKIT N/A
- Revenue Growth
- AKTX N/A
- HKIT N/A
- 52 Week Low
- AKTX $0.85
- HKIT $1.15
- 52 Week High
- AKTX $4.22
- HKIT $1.86
- Technical
- Relative Strength Index (RSI)
- AKTX 43.30
- HKIT 58.02
- Support Level
- AKTX $0.94
- HKIT $1.48
- Resistance Level
- AKTX $1.13
- HKIT $1.58
- Average True Range (ATR)
- AKTX 0.06
- HKIT 0.08
- MACD
- AKTX 0.00
- HKIT -0.00
- Stochastic Oscillator
- AKTX 36.79
- HKIT 56.99
About AKTX Akari Therapeutics plc ADS
Akari Therapeutics PLC is an oncology company developing next-generation antibody-drug conjugates (ADCs) designed around novel, proprietary cancer-killing toxins (payloads). The company believes these novel payloads may have the potential to transform the efficacy and safety outcomes of ADCs as cancer therapies beyond options that are currently available or in development. Its lead product candidate is AKTX-101, a preclinical stage Trop2-targeting ADC that combines PH1 with the Trop2 antibody, which is expressed in the highest number of solid tumor cancer types, including lung, breast, colon and prostate.
About HKIT Hitek Global Inc.
Hitek Global Inc is a provider of information technology consulting and solutions services. The company has two lines of businesses such as services to small and medium businesses, which consist of Anti-Counterfeiting Tax Control System tax devices, including Golden Tax Disk and printers, ACTCS services, and IT services; and services to large businesses, which include hardware sales and software sales. It generates revenues from hardware sales, software sales, IT services, and tax devices and services.